Comparing Egyptian MTA, Biodentine, and Calcium Hydroxide for Indirect Pulp Capping in Adults with Deep Cavities

What this Trial Is About

Researchers are comparing the clinical effectiveness and patient satisfaction of Egyptian MTA, Biodentine, and Calcium Hydroxide when used as indirect pulp capping materials in permanent teeth with deep carious lesions. The study focuses on vital pulp treatments, which aim to preserve the health of dental pulp by stimulating reparative dentin formation without exposing the pulp. This approach helps avoid pulp degeneration and maintains pulp vitality in teeth with deep cavities. Participants will receive one of three treatments involving different pulp capping materials Egyptian MTA, Biodentine, or Calcium Hydroxide. All treatments begin with complete caries removal, followed by the application of the assigned material with light pressure on the deepest cavity area. A light-cured glass ionomer cement base is then applied, selective enamel etching is performed on enamel only, and a universal adhesive system is bonded on enamel and dentin. Finally, a nano hybrid composite resin is incrementally placed to restore the cavity. During the six-month study, participants will be evaluated for treatment success at one week, three months, and six months after the procedure. Researchers will assess clinical outcomes, measure pain levels, and collect patient satisfaction data at these intervals. This double-blind, randomized trial is designed to monitor oral health status and treatment effects over time, helping to determine the best pulp capping material for managing deep caries while maintaining tooth vitality.

Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth